Literature DB >> 21187497

Carbon ion radiotherapy for treatment of prostate cancer and subsequent outcomes after biochemical failure.

Jun Shimazaki1, Hiroshi Tsuji, Hitoshi Ishikawa, Tohru Okada, Koichiro Akakura, Hiroyoshi Suzuki, Masaoki Harada, Hirohiko Tsujii.   

Abstract

BACKGROUND/AIM: Carbon ion radiotherapy is expected to be suitable to treat localized prostate cancer because it yields great biological and physical effects. The aim of this study was to examine long-term results and subsequent outcomes after biochemical failure. PATIENTS AND METHODS: A total of 254 patients were treated from the beginning of 2003 and followed through 2009. Long-term hormone therapy was also used for some intermediate-risk and high-risk patients.
RESULTS: Among the patients examined, 54 patients experienced biochemical failure. Failure-free survival was 76%, 91% and 76% at eight years in low-risk, intermediate-risk and high-risk patients, respectively. Clinical progression occurred only in high-risk patients, with 89% progression-free survival at eight years. After biochemical failure, diseases of most patients were well controlled by salvage therapy but twelve high-risk patients (5%) died of prostate cancer.
CONCLUSION: Carbon ion radiotherapy had an excellent effect on localized prostate cancer. Factors influencing salvage therapy included PSA kinetics and duration between radiation and failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187497

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair.

Authors:  Osama Mohamad; Brock J Sishc; Janapriya Saha; Arnold Pompos; Asal Rahimi; Michael D Story; Anthony J Davis; D W Nathan Kim
Journal:  Cancers (Basel)       Date:  2017-06-09       Impact factor: 6.639

2.  Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Meixuan Li; Xiuxia Li; Liang Yao; Xue Han; Wenlong Yan; Yujun Liu; Yiwen Fu; Yakun Wang; Min Huang; Qiuning Zhang; Xiaohu Wang; Kehu Yang
Journal:  Front Oncol       Date:  2021-10-12       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.